To hear about similar clinical trials, please enter your email below
Trial Title:
Reintegrating a Systematic Review Consultation With the General Practitioner After the Cancer Diagnosis Has Been Announced Into the Complex Cancer Patient Pathway: Feasibility Study
NCT ID:
NCT06589414
Condition:
Solid Tumours
Conditions: Keywords:
Solid Tumours
Announcement system
General practitioner
Study type:
Interventional
Study phase:
N/A
Overall status:
Not yet recruiting
Study design:
Allocation:
N/A
Intervention model:
Single Group Assignment
Primary purpose:
Health Services Research
Masking:
None (Open Label)
Intervention:
Intervention type:
Other
Intervention name:
Patient care according to the DAMeGe protocol (organisation of a summary consultation with the GP)
Description:
A summary consultation with the patient's general practitioner (GP) will take place
within 15 days of the consultation to announce the cancer diagnosis. This patient-general
practitioner consultation will complement the initial consultation.
At the end of the summary consultation, the patient's satisfaction and that of the GP
will be assessed using satisfaction questionnaires.
In addition, patients will be asked to complete a "patient diary" for the duration of
their participation in the study (6 months), in order to record the dates of
consultations with the GP and the dates of consultations and/or hospitalisations at the
referral care centre.
Arm group label:
DAMeGe protocol
Summary:
This is a prospective, multicentric, regional study designed to assess the feasibility of
setting up a summary consultation with a general practitioner (GP) to complement the
consultation for the announcement of a cancer diagnosis.
171 patients will be included in the study.
Each patient will be followed for 6 months.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
1. Age ≥ 18 years.
2. Patient with a solid tumour whatever the organ.
3. Patient treated in one of the participating centres as part of a system for
announcing the diagnosis of a solid cancer.
4. Patient undergoing cancer treatment in one of the participating centres.
5. Patient with a registered general practitioner in the Occitanie region.
6. Patient affiliated to a French Social Security scheme.
7. Patient having signed informed consent prior to inclusion in the study and prior to
any specific procedure for the study.
Exclusion Criteria:
1. Patient already included in another clinical trial concerning a care pathway.
2. Patient deprived of liberty or under legal protection (curatorship and guardianship,
safeguard of justice).
3. Pregnant or breast-feeding woman.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
CH Auch
Address:
City:
Auch
Country:
France
Contact:
Last name:
Vladimir DRUEL
Phone:
05 62 61 32 49
Email:
v.druel@ch-auch.fr
Facility:
Name:
CHU Larrey
Address:
City:
Toulouse
Country:
France
Contact:
Last name:
Julien MAZIERES
Phone:
05 67 77 14 86
Email:
mazieres.j@chu-toulouse.fr
Facility:
Name:
CHU Rangueil
Address:
City:
Toulouse
Country:
France
Contact:
Last name:
Pascale RIVERA
Phone:
05 61 32 21 42
Email:
rivera.p@chu-toulouse.fr
Facility:
Name:
Institut Universitaire du Cancer de Toulouse - Oncopole
Address:
City:
Toulouse
Country:
France
Contact:
Last name:
Jean-Pierre DELORD
Phone:
05 31 15 55 01
Email:
delord.jean-pierre@iuct-oncopole.fr
Start date:
October 2024
Completion date:
October 2026
Lead sponsor:
Agency:
Institut Claudius Regaud
Agency class:
Other
Collaborator:
Agency:
Ligue contre le cancer, France
Agency class:
Other
Source:
Institut Claudius Regaud
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06589414
